WorthPointe, LLC: DFEM position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of WorthPointe, LLC on DFEM, newest first. How the timeline and the estimate are built.
WorthPointe, LLC held 62,805 DFEM shares at 2026-06-30 per its 13F-HR filed 2026-07-31.
the latest 13F is the newest step
- period ended2026-06-3013F 62,805 sharesChange vs previous 13F -2,459 shares
0.64% of the 13F portfolio, value $2,552,377.
13F-HR 0001172661-26-002988 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 65,264 sharesChange vs previous 13F +4,795 shares
0.61% of the 13F portfolio, value $2,254,856.
13F-HR 0001172661-26-001733 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 60,469 sharesChange vs previous 13F +40,362 shares
0.53% of the 13F portfolio, value $2,000,312.
13F-HR 0001172661-26-000300 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 20,107 sharesChange vs previous 13F +12,539 shares
0.24% of the 13F portfolio, value $644,831.
13F-HR 0001172661-25-004324 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 7,568 sharesChange vs previous 13F -410 shares
0.09% of the 13F portfolio, value $224,618.
13F-HR 0001172661-25-002895 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 7,978 sharesChange vs previous 13F not available
0.1% of the 13F portfolio, value $211,098.
13F-HR 0001172661-25-001581 filed by WorthPointe, LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).